Lv61
2060 积分 2023-04-17 加入
Migraine
5天前
已完结
A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome
27天前
已完结
Advances in the treatment of systemic lupus erythematosus
28天前
已完结
Evolving Paradigms in the Management of Systemic Lupus Erythematosus: An Exhaustive Review with Special Emphasis on Pharmaceuticals in Clinical Trials
28天前
已完结
Bruton’s tyrosine kinase: A promising target for treating systemic lupus erythematosus
28天前
已完结
Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2个月前
已完结
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
2个月前
已关闭
Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
2个月前
已完结
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
2个月前
已完结
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
2个月前
已完结
皖公网安备34019202002308
